Shilanski & Associates, Inc. Catalent, Inc. Transaction History

Shilanski & Associates, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $1.34 Million - $1.55 Million	-13,368 Closed	0 $0
Q1 2021 Apr 14, 2021	SELL	$101.51 - $125.27 $5,278 - $6,514	-52 Reduced 0.39%	13,368 $1.41 Million
Q4 2020 Feb 03, 2021	BUY	$85.88 - $105.36 $15,887 - $19,491	185 Added 1.4%	13,420 $1.4 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $9,965 - $12,672	137 Added 1.05%	13,235 $1.13 Million
Q2 2020 Jul 31, 2020	BUY	$48.02 - $79.04 $13,109 - $21,577	273 Added 2.13%	13,098 $960,000
Q1 2020 Apr 14, 2020	BUY	$36.95 - $62.95 $24,423 - $41,609	661 Added 5.43%	12,825 $666,000
Q4 2019 Jan 30, 2020	BUY	$47.06 - $56.64 $36,095 - $43,442	767 Added 6.73%	12,164 $685,000
Q3 2019 Oct 25, 2019	BUY	$47.45 - $58.05 $540,787 - $661,595	11,397 New	11,397 $543,000

422

147M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Shilanski & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Shilanski & Associates, Inc. with notifications on news.